UH

Uwe Haberkorn

RH Ruprecht - Karls - Universität Heidelberg: 11 patents #2 of 222Top 1%
DK Deutsches Krebsforschungszentrum: 10 patents #6 of 345Top 2%
Merck: 3 patents #3,073 of 9,382Top 35%
UH Universität Heidelberg: 2 patents #3 of 112Top 3%
RU Ruprecht-Karls-Universitat: 1 patents #2 of 27Top 8%
📍 Schwetzingen, DE: #7 of 175 inventorsTop 4%
Overall (All Time): #218,363 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDate
12156920 Double-labeled probe for molecular imaging and use thereof Ann-Christin EDER, Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest 2024-12-03
12054458 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer Jens Cardinale, Martin Schaefer, Klaus Kopka, Matthias Eder, Ulrike Bauder-Wuest +3 more 2024-08-06
11638765 Double-labeled probe for molecular imaging and use thereof Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest, Ann-Christin EDER +2 more 2023-05-02
11452786 Double-labeled probe for molecular imaging and use thereof Ann-Christin EDER, Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest 2022-09-27
11020493 Double-labeled probe for molecular imaging and use thereof Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest 2021-06-01
10980901 Treatment of PMSA expressing cancers Alfred Morgenstern, Frank BRUCHERTSEIFER, Christos Apostolidis, Frederik GIESEL, Clemens KRATOCHWIL 2021-04-20
10815200 18F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer Jens Cardinale, Martin Schaefer, Klaus Kopka, Matthias Eder, Ulrike Bauder-Wuest +3 more 2020-10-27
10703796 CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases Alexandra MATZKE-OGI, Véronique Orian-Rousseau, Thomas Lindner, Walter Mier 2020-07-07
10653796 Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules Philipp Uhl, Max Sauter, Walter Mier, Gert Fricker 2020-05-19
10513539 Hydrophobic modified peptides and their use for liver specific targeting Walter Mier, Stephan Urban, Stefan Mehrle 2019-12-24
10471160 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Martin SCHÄFER, Ulrike BAUDER-WÜST, Michael Eisenhut +4 more 2019-11-12
10413614 Conjugates for protection from nephrotoxic active substances Armin Kuebelbeck, Gregor Larbig, Stefan Arnold, Walter Mier 2019-09-17
10406246 Double-labeled probe for molecular imaging and use thereof Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest 2019-09-10
10398791 Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Martin SCHÄFER, Ulrike BAUDER-WÜST, Michael Eisenhut +2 more 2019-09-03
10363323 Hydrophobic modified peptides for liver specific diagnosis Walter Mier, Stephan Urban, Stefan Mehrle, Thomas Müller, Vasileios ASKOXYLAKIS 2019-07-30
10253099 Conjugates of proteins and multivalent cell-penetrating peptides and their uses Matthias Strieker, Walter Mier 2019-04-09
10016519 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer Klaus Kopka, Martina Benesova, Jens Cardinale, Matthias Eder, Martin SCHÄFER +2 more 2018-07-10
9868768 Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver Walter Mier, Stephan Urban 2018-01-16
9808535 Conjugates for protection from nephrotoxic active substances Armin Kuebelbeck, Gregor Larbig, Stefan Arnold, Walter Mier 2017-11-07
9078929 ε-Polylysine conjugates and the use thereof Armin Kuebelbeck, Gregor Larbig, Walter Mier, Barbro Beijer 2015-07-14